[HTML][HTML] Clinical guide to ABO-incompatible allogeneic stem cell transplantation

GS Booth, EA Gehrie, CD Bolan, BN Savani - Biology of Blood and Marrow …, 2013 - Elsevier
The independent genomic inheritance of the human leukocyte antigen (HLA) and the ABO-
blood group system allows for HLA-matched hematopoietic progenitor cell transplantation …

[HTML][HTML] Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols

RA Montgomery - American Journal of Transplantation, 2010 - Elsevier
The field of desensitization and incompatible transplantation has made great gains over the
past decade. There are now several options and effective therapies for many patients who …

KDIGO clinical practice guideline on the evaluation and care of living kidney donors

KL Lentine, BL Kasiske, AS Levey, PL Adams… - …, 2017 - journals.lww.com
Abstract The 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Care of Living Kidney Donors is intended to assist medical …

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation

BD Tait, C Süsal, HM Gebel, PW Nickerson… - …, 2013 - journals.lww.com
Background The introduction of solid-phase immunoassay (SPI) technology for the detection
and characterization of human leukocyte antigen (HLA) antibodies in transplantation while …

Survival benefit with kidney transplants from HLA-incompatible live donors

BJ Orandi, X Luo, AB Massie… - … England Journal of …, 2016 - Mass Medical Soc
Background A report from a high-volume single center indicated a survival benefit of
receiving a kidney transplant from an HLA-incompatible live donor as compared with …

Desensitization in HLA-incompatible kidney recipients and survival

RA Montgomery, BE Lonze, KE King… - … England Journal of …, 2011 - Mass Medical Soc
Background More than 20,000 candidates for kidney transplantation in the United States are
sensitized to HLA and may have a prolonged wait for a transplant, with a reduced …

IdeS (Imlifidase): a novel agent that cleaves human IgG and permits successful kidney transplantation across high-strength donor-specific antibody

BE Lonze, VS Tatapudi, EP Weldon, ES Min… - Annals of …, 2018 - journals.lww.com
Objectives: The presence of a donor-specific positive crossmatch has been considered to be
a contraindication to kidney transplantation because of the risk of hyperacute rejection …

ABO-incompatible kidney transplant outcomes: a meta-analysis

AE de Weerd, MGH Betjes - … Journal of the American Society of …, 2018 - journals.lww.com
Results After identifying 2728 studies addressing ABO-incompatible kidney transplantation,
26 studies were included, describing 1346 unique patients who were ABO-incompatible and …

Outcomes of ABO-incompatible kidney transplantation in the United States

JR Montgomery, JC Berger, DS Warren… - …, 2012 - journals.lww.com
Background. ABO incompatible (ABOi) kidney transplantation is an important modality to
facilitate living donor transplant for incompatible pairs. To date, reports of the outcomes from …

[HTML][HTML] ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management

M Okumi, D Toki, T Nozaki, T Shimizu… - American Journal of …, 2016 - Elsevier
ABO-incompatible living kidney transplantation (ABO-ILKT) has steadily become more
widespread. However, the optimal immunosuppressive regimen for ABO-ILKT remains …